ARK Investment Management LLC
Position in NRIX — Nurix Therapeutics, Inc.
CIK 1697748
ST. PETERSBURG, FL
Position in NRIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$43,502,934
+$16,825,342 QoQ
Shares Held
1,793,196
+4.2% QoQ
Ownership
1.73%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#16
of 210 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ARK Investment Management LLC holds $1,628,434,493 across 17 Biotechnology names. NRIX ranks #6 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
9,460,939 | $515,999,613 | |
| 2 | BEAM |
Beam Therapeutics Inc.
|
10,234,862 | $351,260,463 | |
| 3 | NTLA |
Intellia Therapeutics, Inc.
|
16,875,684 | $285,536,573 | |
| 4 | RXRX |
Recursion Pharmaceuticals, Inc.
|
41,337,632 | $151,709,109 | |
| 5 | ABSI |
Absci Corp
|
12,925,271 | $149,803,890 | |
| 6 | NRIX |
Nurix Therapeutics, Inc.
This page
|
1,793,196 | $43,502,934 | |
| 7 | PRME |
Prime Medicine, Inc.
|
8,348,746 | $30,806,872 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
300,770 | $23,848,053 |
All Filings in NRIX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43,502,934 | 1,793,196 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $26,677,592 | 1,721,135 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $30,400,164 | 1,602,539 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $13,956,132 | 1,510,404 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $17,939,614 | 1,575,032 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $18,900,010 | 1,590,910 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $28,830,720 | 1,530,293 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $49,801,721 | 2,216,365 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $48,487,938 | 2,323,332 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $38,739,468 | 2,635,338 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $32,972,389 | 3,194,999 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $20,381,349 | 2,593,047 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $22,588,099 | 2,261,071 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $19,889,947 | 2,239,859 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $21,831,028 | 1,988,254 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $16,763,381 | 1,286,522 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $9,866,445 | 778,725 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $5,491,793 | 391,991 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $1,272,265 | 43,947 | Shares | Sole | 2022-01-28 | |
| No filing history on record for this holder in this stock. | ||||||